Read more about the article Study showed that vaping is linked to respiratory symptoms but according to CoEHAR researchers: “No causality proved”

Study showed that vaping is linked to respiratory symptoms but according to CoEHAR researchers: “No causality proved”

Post author:Chiara Nobis
Post published:8 August 2022
Post category:Press Release

The prestigious American Journal of Respiratory and Critical Care Medicine published a comment by researchers from CoEHAR and the University of Messina regarding a US studies that concluded that “former and current e-cigarette use was associated with higher odds of developing wheezing-related respiratory symptoms”. According to the Italian authors “the significance of the findings needs careful review”.

Evidence for Clinicians: E-Cigarettes a Better Chance at Health

Post author:Chiara Nobis
Post published:12 July 2022
Post category:In Silico Press Release

The In Silico Science research team conducted a series of robust and exhaustive systematic reviews to bring forward the best available evidence on the health effects of e-cigarettes on human health developing data for clinicians

Covid-19: ecig only add 1% of risk compared to breathing

Post author:Chiara Nobis
Post published:30 June 2022
Post category:Press Release

Incredibly, people close to an infected vaper using an e-cigarette in home or restaurant scenarios face a one percent increase of risk of contagion compared to the control case of a normal breathing (without vaping) inside closed spaces. This relative added risk becomes 5-17 percent for high intensity vaping and up to 260 percent for speaking for various periods and coughing.

US: end of teen nicotine vaping epidemic and eradication of tobacco smoking

Post author:Chiara Nobis
Post published:23 June 2022
Post category:Press Release

The use of e-cigarette among teenagers in the United States is considered a significant public health problem. A close look at federal data now show that the number of young e-cigarette users has markedly declined to below epidemic levels since its peak in 2019.

The first review to assess the metabolic impact of stopping smoking in patients with diabetes mellitus revealed serious gaps in the literature

Post author:Chiara Nobis
Post published:20 June 2022
Post category:Diasmoke Press Release

Quitting smoking can reduce cardiovascular and kidney failure risks. However, it can lead to side effects such as weight gain. A scoping review conducted by a pool of European researchers revealed a lack of data on the metabolic effects of smoking and smoking cessation in diabetes. Healthcare professionals should not assume that cessation of smoking will improve metabolic parameters in patients with diabetes.

CoEHAR and ANPVU to Commissioner Kyriakides: ecig as aids for smoking cessation

Post author:Chiara Nobis
Post published:25 May 2022
Post category:Press Release

Prof. Riccardo Polosa, Founder of the CoEHAR, and Carmine Canino, President of ANPVU, National Association of ecig consumers, have sent a letter to the European Commissioner for Health Stella Kyriakides, regarding her statements on the effectiveness of e-cigarettes to quit smoking.

Health risks of nicotine products: FSFW webinar. Polosa, O’Leary speakers

Post author:Chiara Nobis
Post published:3 May 2022
Post category:Press Release In Silico

The Foundation for a Smoke Free World (FSFW) will host a free 60-minute public economics webinar to discuss the latest news regarding electronic nicotine delivery systems. Join the meeting Thursday, May 12, 2022 at 9.00AM US EST

CoEHAR study on ecig flavored liquids: samples are 80% lower risk than smoking

Post author:Chiara Nobis
Post published:21 April 2022
Post category:Press Release

The results of the study published by the prestigious scientific magazine “Drug Testing & Analysis” showed no contaminants in all e-liquids and a metal content below the levels permitted by WHO for drinking-waters

alfio distefano experimental biology

Experimental Biology 2022: CoEHAR flies to Philadelphia to present the Replica project

Post author:Chiara Nobis
Post published:4 April 2022
Post category:Press Release Replica

CoEHAR presented the results of the Replica project during Experimental Biology 2022, the annual meeting that brings together thousands of scientists and experts in the field of anatomy, biochemistry and molecular biology, investigative pathology, pharmacology, and physiology. Representing CoEHAR, the researcher Alfio Distefano, PhD student in neuroscience at the University of Catania

SRNT 2022: focus on health equity, research and innovation

Post author:Chiara Nobis
Post published:15 March 2022
Post category:Press Release

The annual meeting of SRNT, the Society for Research on Nicotine and Tobacco, kicks off on March 15. The conference will host a panel of international experts to discuss the latest news on policy, smoking endgame strategies, scientific research and innovation